AWS expands AI in healthcare through a Memorial Sloan Kettering partnership

Full Article

Amazon Web Services (AMZN) is expanding its influence in healthcare by forming partnerships aimed at enhancing AI capabilities. Recently, a collaboration with Memorial Sloan Kettering (MSK) was announced, focusing on developing treatments for cancer patients and improving cancer research tracking. This partnership aims to create a comprehensive data resource that will aid in personalizing treatments and improving patient care through advanced data analysis.

The partnership will enable MSK researchers to monitor cancer progression using computable disease trajectories, which can lead to new insights in treatment personalization. Despite the excitement surrounding AI, MSK's chief strategy officer, Dr. Anaeze Offodile II, emphasized the technology's nascent stage and the importance of collaboration in evaluating its potential. AWS's ongoing relationships with other healthcare companies, like GE HealthCare, further illustrate its commitment to advancing AI in the medical field.

• AWS partners with MSK to enhance cancer treatment through AI.

• MSK aims to track cancer progression using advanced data analysis.

Key AI Terms Mentioned in this Article

AI Capabilities

AI capabilities refer to the potential of artificial intelligence to analyze data and improve healthcare outcomes.

Longitudinal Data Resource

A longitudinal data resource is a comprehensive dataset that tracks changes over time, crucial for cancer research.

Computable Disease Trajectories

Computable disease trajectories are data models that help in tracking the progression of diseases like cancer.

Companies Mentioned in this Article

Amazon Web Services

AWS is enhancing healthcare through AI partnerships, focusing on cancer treatment advancements.

Memorial Sloan Kettering

MSK collaborates with AWS to develop AI-driven insights for personalized cancer treatments.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 3month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 3month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 3month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 3month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics